BOT 5.48% 34.5¢ botanix pharmaceuticals ltd

Read the Euroz Hartleys report (13 may 24) ......says it in...

  1. 408 Posts.
    lightbulb Created with Sketch. 217
    Read the Euroz Hartleys report (13 may 24) ......says it in there (& I've read elsewhere) - the sale of SOFDRA has a high profit margin BOT have said that themselves. The report mentioned above - also says that.....Sofdra is to sell for around $720 /script GROSS price (to match the competitor being Qbrexxa). It also says that will mean $540/script NET PRICING for sofdra.....to me that means - after ALL/majority of costs involved for SOFDRA....that's what each unit sale is worth to Botanix.
    I've posted/mentioned this very recently on HC...simple really. Work your dream on that ($540/script.....maybe even $500/script if you like - WHICH IS AFTER ALL COSTS)......then let us know how it plays out in your calcs!
    It is all written/announced previously - not makin this stuff up - I guess the sales & take up will tell. But we also know how that's been panning out so far for Japan don't we!
    fuk...I'm just a little bit excited hey..
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.020(5.48%)
Mkt cap ! $543.4M
Open High Low Value Volume
35.5¢ 35.5¢ 34.0¢ $4.566M 13.13M

Buyers (Bids)

No. Vol. Price($)
11 410003 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 346713 8
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.